Cell-cycle markers in a transgenic mouse model of human tauopathy: increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1

The American Journal of Pathology
Patrice DelobelM Goedert

Abstract

Recent evidence has suggested that an abnormal reactivation of the cell cycle may precede and cause the hyperphosphorylation and filament formation of tau protein in Alzheimer's disease and other tauopathies. Here we have analyzed the expression and/or activation of proteins involved in cell-cycle progression in the brain and spinal cord of mice transgenic for mutant human P301S tau protein. This mouse line recapitulates the essential molecular and cellular features of the human tauopathies, including hyperphosphorylation and filament formation of tau protein. None of the activators and co-activators of the cell cycle tested were overexpressed or activated in 5-month-old transgenic mice when compared to controls. By contrast, the levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1 were increased in brain and spinal cord of transgenic mice. Both inhibitors accumulated in the cytoplasm of nerve cells, the majority of which contained inclusions made of hyperphosphorylated tau protein. A similar staining pattern for p21Cip1 and p27Kip1 was also present in the frontal cortex from a case of FTDP-17 with the P301L tau mutation. Thus, reactivation of the cell cycle was not involved in tau hyperphos-phorylation and filament...Continue Reading

References

Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M R al-UbaidiW Baehr
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Dec 16, 1993·Nature·Y XiongD Beach
Feb 1, 1996·The Journal of Cell Biology·I VincentP Davies
Dec 1, 1996·Journal of Neurochemistry·C M Kondratick, D D Vandré
Jul 1, 1997·Acta Neuropathologica·Z NagyA D Smith
Jun 18, 1998·Annals of Neurology·P PoorkajG D Schellenberg
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·M G SpillantiniB Ghetti
Nov 13, 1998·Current Opinion in Neurobiology·M GoedertS W Davies
Apr 28, 1999·Journal of Neuropathology and Experimental Neurology·S S MirraB Ghetti
May 15, 1999·Dementia and Geriatric Cognitive Disorders·Y TsujiokaT Yamada
Sep 1, 2000·Brain Research. Brain Research Reviews·L BuéeP R Hof
Oct 3, 2000·The Journal of Biological Chemistry·J GötzR M Nitsch
Dec 22, 2000·Neurobiology of Aging·J W HussemanI Vincent
Dec 22, 2000·Neurobiology of Aging·P L HarrisM A Smith
Aug 25, 2001·Annual Review of Neuroscience·V M LeeJ Q Trojanowski
Jan 5, 2002·Journal of Neuropathology and Experimental Neurology·J W HussemanI Vincent
Apr 10, 2002·Journal of Neuropathology and Experimental Neurology·Kelly L Jordan-SciuttoRobert Bowser
Aug 3, 2002·Journal of Neuropathology and Experimental Neurology·Jeroen J M HoozemansThomas Arendt
Sep 6, 2002·Journal of Alzheimer's Disease : JAD·Andrei TomashevskiInez Vincent

❮ Previous
Next ❯

Citations

Jul 20, 2007·European Archives of Psychiatry and Clinical Neuroscience·H Georg KuhnPaul J Lucassen
Feb 8, 2008·Genes, Brain, and Behavior·K SchindowskiL Buée
Jan 24, 2009·Trends in Neurosciences·Tara L Spires-JonesBradley T Hyman
Dec 5, 2006·Biochimica Et Biophysica Acta·Xiongwei ZhuMark A Smith
Sep 29, 2018·International Journal of Molecular Sciences·Marios KritsilisDimitrios Papadopoulos
Jun 6, 2009·Neuroreport·José J RodríguezAlexei Verkhratsky
May 28, 2010·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Masahiro Hitomi, Dennis W Stacey
Nov 22, 2019·Journal of Neuropathology and Experimental Neurology·Masataka NakamuraHirofumi Kusaka
May 12, 2007·Brain Pathology·Jürgen GötzLars M Ittner
Aug 25, 2019·International Journal of Molecular Sciences·Serena SilvestroEmanuela Mazzon
Feb 6, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zizhen SiXidi Wang
Dec 15, 2007·The American Journal of Pathology·Patrice DelobelMichel Goedert
Dec 5, 2006·Biochimica Et Biophysica Acta·Vikram Khurana, Mel B Feany

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Related Papers

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Tara VanderweydeBenjamin Wolozin
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Cathy AndorferPeter Davies
European Archives of Psychiatry and Clinical Neuroscience
H Georg KuhnPaul J Lucassen
© 2021 Meta ULC. All rights reserved